semaglutide off shortage list Ozempic and Wegovy removed from the FDA's drug FDA declares semaglutide (Ozempic/Wegovy) shortage

Share it in the comments below Our team Dr Franziska Meuschel Kay Willis Annie Khenian Khalid Dar Dr Peter Gruenewald Teresa Orea Dr Marco Cortez Catherine Rogers Mounir Mehhat Lucy Beavis Lucie Lucas Trutschler Dieter #morethanhealth #seasonalmedicine #longevity #guthealth #functionalmedicine #holistichealth #nutrition #digestivehealth #gutmicrobiome #preventativemedicine #wellnesstips #autogenictraining #coldwater #oestopathy #fxmayr #microimmunotherapy #biohacking #immunesupport #ultraprocessedfoods To view or add a comment, sign in 2,892 followers

Casanueva FF, Moreno B, Rodriguez-Azeredo R, Massien C, Conthe P, Formiguera X, et al

Early evidence from the development of dual and triple combination agents suggests that GLP-1 receptor agonists will probably become popular treatment options for patients with T2DM

King, W

J Clin Endocrinol Metab 37: 826828, 1973

In knee OA, clinical data suggest that GLP-1RAs improve pain and function and reduce the risk of surgical intervention